BioStock: BrainCool and KI conduct major cardiac arrest study

BrainCool will deliver its products RhinoChill and BrainCool System to Karolinska Institutet for a large international clinical study pre-hospital cooling of cardiac arrest patients. In a comment to BioStock, CEO Martin Waleij says that the deal value of 3 million SEK is secondary to the fact that RhinoChill can become central in the future treatment of cardiac arrest.

Read the full interview with Martin Waleij at biostock.se:

https://www.biostock.se/en/2023/03/braincool-and-ki-conduct-major-cardiac-arrest-study/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/